These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25072363)

  • 41. A cost and resource utilization analysis of micafungin bridging for hemato-oncological high-risk patients undergoing allogeneic stem cell transplantation.
    Heimann SM; Vehreschild MJ; Cornely OA; Franke B; von Bergwelt-Baildon M; Wisplinghoff H; Kron F; Scheid C; Vehreschild JJ
    Eur J Haematol; 2015 Jun; 94(6):526-31. PubMed ID: 25310918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Echinocandin use in the neonatal intensive care unit.
    Caudle KE; Inger AG; Butler DR; Rogers PD
    Ann Pharmacother; 2012 Jan; 46(1):108-16. PubMed ID: 22190252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Echinocandins: the newest class of antifungals.
    Sucher AJ; Chahine EB; Balcer HE
    Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and pharmacokinetics of repeat-dose micafungin in young infants.
    Benjamin DK; Smith PB; Arrieta A; Castro L; Sánchez PJ; Kaufman D; Arnold LJ; Kovanda LL; Sawamoto T; Buell DN; Hope WW; Walsh TJ
    Clin Pharmacol Ther; 2010 Jan; 87(1):93-9. PubMed ID: 19890251
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Micafungin for therapy of invasive candidiasis in solid organ transplant recipients].
    Fortún-Abete J
    Rev Iberoam Micol; 2009 Mar; 26(1):65-8. PubMed ID: 19463280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety of micafungin in pediatric clinical trials.
    Arrieta AC; Maddison P; Groll AH
    Pediatr Infect Dis J; 2011 Jun; 30(6):e97-e102. PubMed ID: 21378595
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered Micafungin Pharmacokinetics in Intensive Care Unit Patients.
    Lempers VJ; Schouten JA; Hunfeld NG; Colbers A; van Leeuwen HJ; Burger DM; Verweij PE; Pickkers P; Brüggemann RJ
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4403-9. PubMed ID: 25963988
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug interactions between micafungin at high doses and cyclosporine A in febrile neutropenia patients after allogeneic hematopoietic stem cell transplantation.
    Inoue Y; Saito T; Ogawa K; Nishio Y; Kosugi S; Suzuki Y; Kato M; Sakai T; Takahashi M; Miura I
    Int J Clin Pharmacol Ther; 2012 Nov; 50(11):831-7. PubMed ID: 22943928
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of special patient populations on the pharmacokinetics of echinocandins.
    Muilwijk EW; Lempers VJ; Burger DM; Warris A; Pickkers P; Aarnoutse RE; Brüggemann RJ
    Expert Rev Anti Infect Ther; 2015 Jun; 13(6):799-815. PubMed ID: 25947367
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of micafungin regimens by pharmacokinetic-pharmacodynamic analysis: a dosing strategy for Aspergillus infections.
    Ikawa K; Nomura K; Morikawa N; Ikeda K; Taniwaki M
    J Antimicrob Chemother; 2009 Oct; 64(4):840-4. PubMed ID: 19700475
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A study to determine the safety profile and maximum tolerated dose of micafungin (FK463) in patients undergoing haematopoietic stem cell transplantation.
    Sirohi B; Powles RL; Chopra R; Russell N; Byrne JL; Prentice HG; Potter M; Koblinger S
    Bone Marrow Transplant; 2006 Jul; 38(1):47-51. PubMed ID: 16715107
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative Population Plasma and Tissue Pharmacokinetics of Micafungin in Critically Ill Patients with Severe Burn Injuries and Patients with Complicated Intra-Abdominal Infection.
    García-de-Lorenzo A; Luque S; Grau S; Agrifoglio A; Cachafeiro L; Herrero E; Asensio MJ; Sánchez SM; Roberts JA
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5914-21. PubMed ID: 27458229
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Population pharmacokinetics of micafungin in neonates and young infants.
    Hope WW; Smith PB; Arrieta A; Buell DN; Roy M; Kaibara A; Walsh TJ; Cohen-Wolkowiez M; Benjamin DK
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2633-7. PubMed ID: 20308367
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Administration of micafungin as prophylactic antifungal therapy in patients undergoing allogeneic stem cell transplantation.
    Hashino S; Morita L; Takahata M; Onozawa M; Nakagawa M; Kawamura T; Fujisawa F; Kahata K; Izumiyama K; Yonezumi M; Chiba K; Kondo T; Asaka M
    Int J Hematol; 2008 Jan; 87(1):91-7. PubMed ID: 18224421
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Different doses of micafungin for prophylaxis of invasive fungal diseases in hemato-oncological high-risk patients: a web-based non-interventional trial in four large university hospitals in Germany.
    Heimann SM; Vehreschild MJ; Meintker L; Heinz W; Schroeder T; von Bergwelt-Baildon M; Cornely OA; Vehreschild JJ
    Transpl Infect Dis; 2014 Dec; 16(6):968-74. PubMed ID: 25371351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma and peritoneal fluid population pharmacokinetics of micafungin in post-surgical patients with severe peritonitis.
    Grau S; Luque S; Campillo N; Samsó E; Rodríguez U; García-Bernedo CA; Salas E; Sharma R; Hope WW; Roberts JA
    J Antimicrob Chemother; 2015 Oct; 70(10):2854-61. PubMed ID: 26180134
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Micafungin versus amphotericin B lipid complex for the prevention of invasive fungal infections in high-risk liver transplant recipients.
    Sun HY; Cacciarelli TV; Singh N
    Transplantation; 2013 Sep; 96(6):573-8. PubMed ID: 23842191
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Micafungin: a new echinocandin antifungal.
    Joseph JM; Jain R; Danziger LH
    Pharmacotherapy; 2007 Jan; 27(1):53-67. PubMed ID: 17192162
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants.
    Heresi GP; Gerstmann DR; Reed MD; van den Anker JN; Blumer JL; Kovanda L; Keirns JJ; Buell DN; Kearns GL
    Pediatr Infect Dis J; 2006 Dec; 25(12):1110-5. PubMed ID: 17133155
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of micafungin for the prophylaxis of invasive fungal infection during neutropenia in children and adolescents undergoing allogeneic hematopoietic SCT.
    Park HJ; Park M; Han M; Nam BH; Koh KN; Im HJ; Lee JW; Chung NG; Cho B; Kim HK; Yoo KH; Koo HH; Kang HJ; Shin HY; Ahn HS; Lim YT; Kook H; Lyu CJ; Hah JO; Park JE; Lim YJ; Seo JJ
    Bone Marrow Transplant; 2014 Sep; 49(9):1212-6. PubMed ID: 25000455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.